Monach Paul A
Vasculitis Center and Section of Rheumatology, Boston University School of Medicine, 72 East Concord Street, E-533, Boston, MA, 02118, USA,
Curr Treat Options Cardiovasc Med. 2013 Apr;15(2):214-23. doi: 10.1007/s11936-013-0232-y.
Having diagnosed a patient as having IgG4-related disease, I would have a low threshold for recommending immune-suppressive treatment, and would make that recommendation for any patient with vascular involvement. My initial approach would be prednisone at 40-60 mg/day with a plan to reduce the dose every two weeks, e.g., 40, 30, 20, 15, 10, 7.5, 5, and 2.5 mg for 2 weeks each. In the event of relapse, I would double the current prednisone dose, slow the taper, and add azathioprine, anticipating using that drug for one year if the patient were to remain in remission. In the event or subsequent relapse, I would stop azathioprine and use rituximab. In a patient with large artery involvement, I would consult a vascular surgeon soon after diagnosis, anticipating a need for surgical repair.
一旦诊断出患者患有IgG4相关疾病,我会毫不犹豫地推荐免疫抑制治疗,对于任何有血管受累的患者都会给出此建议。我最初的治疗方法是使用泼尼松,剂量为每天40 - 60毫克,并计划每两周减少剂量,例如,每次2周的剂量分别为40、30、20、15、10、7.5、5和2.5毫克。如果复发,我会将当前泼尼松剂量加倍,减缓减量速度,并加用硫唑嘌呤,预计如果患者保持缓解状态,该药物将使用一年。如果再次复发,我会停用硫唑嘌呤并使用利妥昔单抗。对于有大动脉受累的患者,我会在诊断后尽快咨询血管外科医生,预计可能需要进行手术修复。